His primary areas of study are Cannabinoid, Cannabinoid receptor, Pharmacology, Cannabinoid receptor type 2 and Cannabinoid Receptor Agonists. His Cannabinoid research incorporates elements of Agonist, Anandamide, Stereochemistry and Endocannabinoid system. His biological study spans a wide range of topics, including Endocrinology, Cannabinol and Neuroscience.
The various areas that Roger G. Pertwee examines in his Pharmacology study include Cannabinoid Receptor Modulators, Tetrahydrocannabivarin, Cannabidiol, Cannabis and GPR18. The study incorporates disciplines such as Immunology, Molecular biology and AM251 in addition to Cannabinoid receptor type 2. His Cannabinoid Receptor Agonists research integrates issues from Cannabinoid receptor antagonist and URB597.
His scientific interests lie mostly in Cannabinoid, Pharmacology, Cannabinoid receptor, Cannabinoid receptor type 2 and Receptor. The Cannabinoid study combines topics in areas such as Agonist, Anandamide, Endocrinology and Stereochemistry. His research investigates the connection between Pharmacology and topics such as Cannabidiol that intersect with problems in Neuroprotection.
His Cannabinoid receptor research includes elements of Inverse agonist and Endocannabinoid system. Roger G. Pertwee has researched Endocannabinoid system in several fields, including Allosteric modulator and Neuroscience. The various areas that Roger G. Pertwee examines in his Cannabinoid receptor type 2 study include Cannabinoid Receptor Modulators and AM251.
The scientist’s investigation covers issues in Cannabinoid receptor, Pharmacology, Cannabinoid, Receptor and Endocannabinoid system. His study in Cannabinoid receptor focuses on Cannabinoid Receptor Agonists, Anandamide and Cannabinoid receptor antagonist. His Pharmacology study integrates concerns from other disciplines, such as Tetrahydrocannabivarin, Allosteric regulation, Cannabidiol and Receptor antagonist.
His research in Cannabinoid intersects with topics in Allosteric modulator, Endocrinology, Regulatory sequence and Cannabinoid receptor type 2. He combines subjects such as Stereochemistry and In vivo with his study of Receptor. His Endocannabinoid system study also includes
Roger G. Pertwee focuses on Pharmacology, Cannabinoid receptor, Cannabinoid, Endocannabinoid system and Receptor. His biological study spans a wide range of topics, including Dopaminergic, Cannabidiol, Metabotropic receptor, Cannabinoid receptor type 1 and In vivo. His research in Cannabinoid receptor type 2, Cannabinoid Receptor Agonists and Cannabinoid receptor antagonist are components of Cannabinoid receptor.
Roger G. Pertwee interconnects Depolarization-induced suppression of inhibition, Virodhamine and GPR18 in the investigation of issues within Cannabinoid Receptor Agonists. Cannabinoid is a subfield of Internal medicine that he studies. His Agonist and Cannabidiolic acid study in the realm of Receptor interacts with subjects such as Cannabis sativa.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR
William A. Devane;Lumir Hanuš;Aviva Breuer;Roger G. Pertwee.
Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors.
Raphael Mechoulam;Shimon Ben-Shabat;Lumir Hanus;Moshe Ligumsky.
Biochemical Pharmacology (1995)
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
A C Howlett;F Barth;T I Bonner;G Cabral.
Pharmacological Reviews (2002)
PHARMACOLOGY OF CANNABINOID CB1 AND CB2 RECEPTORS
Roger G. Pertwee.
Pharmacology & Therapeutics (1997)
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: Δ9-tetrahydrocannabinol, cannabidiol and Δ9-tetrahydrocannabivarin
R G Pertwee.
British Journal of Pharmacology (2008)
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2
Roger Guy Pertwee;A. C. Howlett;M. E. Abood;S. P. H. Alexander.
Pharmacological Reviews (2010)
Cannabinoid receptors and pain.
Roger Guy Pertwee.
Progress in Neurobiology (2001)
Pharmacological actions of cannabinoids.
R. G. Pertwee.
Handbook of experimental pharmacology (2005)
Cannabinoids control spasticity and tremor in a multiple sclerosis model.
D Baker;G Pryce;J L Croxford;P Brown.
Pharmacology of cannabinoid receptor ligands.
Current Medicinal Chemistry (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: